The aim of the present study was to investigate the role of three hypoxia-related biomarkers in patients with locally advanced head and neck squamous cell carcinoma (HNSCC) treated with concurrent chemoradiotherapy (3-weekly cisplatin) or bioradiotherapy (weekly cetuximab).
http://ift.tt/2leLTL8
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου